Alkermes Plc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ALKS Nasdaq 8731 http://www.alkermes.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alkermes Plc

Esperion (ESPR) Up More Than 12% YTD: What's Driving the Rally? - May 26th, 2022 2:01 pm
Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now - May 26th, 2022 10:07 am
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease - May 25th, 2022 6:29 pm
Here's Why You Must Add Masimo (MASI) Stock to Your Portfolio - May 25th, 2022 3:02 pm
Masimo's (MASI) PVi Favored by New Study for Pediatric Patients - May 25th, 2022 3:02 pm
Here's Why You Should Retain Amedisys (AMED) Stock for Now - May 25th, 2022 2:38 pm
Pfizer (PFE) Reports More Positive Data From Etrasimod Study - May 25th, 2022 12:41 pm
Merck (MRK) Keytruda Gets EU Nod for Expanded Breast Cancer Use - May 25th, 2022 12:35 pm
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Revised) - May 25th, 2022 5:09 am
Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva - May 24th, 2022 7:03 pm
Shockwave Medical's (SWAV) IVL Cleared for Use in China - May 24th, 2022 3:21 pm
Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable - May 24th, 2022 3:20 pm
Biohaven's (BHVN) Zavegepant NDA for Migraine Accepted by FDA - May 24th, 2022 1:47 pm
Treating Bipolar 1 Disorder - May 24th, 2022 1:01 pm
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal - May 23rd, 2022 7:32 pm
Regeneron's (REGN) Evkeeza Positive in Late-Stage Study - May 23rd, 2022 4:26 pm
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA - May 23rd, 2022 3:46 pm
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock - May 23rd, 2022 3:22 pm
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication - May 23rd, 2022 2:20 pm
Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use - May 23rd, 2022 2:14 pm